3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
81
Colorectal Neoplasms
72
Rectal Neoplasms
47
Colonic Neoplasms
25
Pancreatic Neoplasms
24
Neoplasm Metastasis
17
Carcinoma, Hepatocellular
17
Esophageal Neoplasms
11
Cholangiocarcinoma
9
Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
7
Liver Neoplasms
7
Biliary Tract Neoplasms
6
Colorectal Cancer Metastatic
5
Carcinoma, Non-Small-Cell Lung
5
Recurrence
4
Lymphoma, Extranodal NK-T-Cell
4
Gallbladder Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Locally Advanced Rectal Cancer
3
Gastrointestinal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Adenocarcinoma
3
Solid Tumors
2
Solid Tumor
2
Ovarian Neoplasms
2
Neurotoxicity Syndromes
2
Lymphoma
2
Lung Neoplasms
2
Locally Advanced Colon Cancer
2
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Metastatic Pancreatic Adenocarcinoma
×
Oxaliplatin
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled